Next Article in Journal
A Comprehensive Molecular and Clinical Investigation of Approved Anti-HCV Drugs Repurposing against SARS-CoV-2 Infection: A Glaring Gap between Benchside and Bedside Medicine
Next Article in Special Issue
Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV-Infected Patients—Real-World Study
Previous Article in Journal
A DNA Vaccine Encoding the Full-Length Spike Protein of Beta Variant (B.1.351) Elicited Broader Cross-Reactive Immune Responses against Other SARS-CoV-2 Variants
Previous Article in Special Issue
The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses
 
 
Brief Report

Article Versions Notes

Vaccines 2023, 11(3), 514; https://doi.org/10.3390/vaccines11030514
Action Date Notes Link
article pdf uploaded. 22 February 2023 15:41 CET Version of Record https://www.mdpi.com/2076-393X/11/3/514/pdf-vor
article xml file uploaded 27 February 2023 11:09 CET Original file -
article xml uploaded. 27 February 2023 11:09 CET Update https://www.mdpi.com/2076-393X/11/3/514/xml
article pdf uploaded. 27 February 2023 11:09 CET Updated version of record https://www.mdpi.com/2076-393X/11/3/514/pdf
article html file updated 27 February 2023 11:10 CET Original file -
article html file updated 27 February 2023 11:19 CET Update -
article html file updated 9 March 2023 22:07 CET Update https://www.mdpi.com/2076-393X/11/3/514/html
Back to TopTop